Comments
Loading...
Gentex Analyst Ratings and Price Targets | NASDAQ:GNTX | Benzinga
Gentex Corp has a consensus price target of $28.19 based on the ratings of 8 analysts. The high is $35 issued by B of A Securities on October 14, 2024. The low is $21 issued by UBS on April 10, 2025. The 3 most-recent analyst ratings were released by Guggenheim, Baird, and UBS on April 22, 2025, April 15, 2025, and April 10, 2025, respectively. With an average price target of $23.33 between Guggenheim, Baird, and UBS, there's an implied 4.21% upside for Gentex Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Baird
UBS
Goldman Sachs
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for Gentex
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/22/2025 | Buy Now | 7.19% | Guggenheim | Ronald Jewsikow48% | $30 → $24 | Maintains | Buy | Get Alert |
| 04/15/2025 | Buy Now | 11.66% | Baird | David Leiker59% | $31 → $25 | Downgrade | Outperform → Neutral | Get Alert |
| 04/10/2025 | Buy Now | -6.21% | UBS | Joseph Spak43% | $29 → $21 | Maintains | Neutral | Get Alert |
| 04/10/2025 | Buy Now | 2.72% | Goldman Sachs | Mark Delaney77% | $28 → $23 | Maintains | Neutral | Get Alert |
| 02/03/2025 | Buy Now | 29.52% | UBS | Joseph Spak43% | $30 → $29 | Maintains | Neutral | Get Alert |
| 02/03/2025 | Buy Now | 45.15% | B. Riley Securities | Josh Nichols50% | $37 → $32.5 | Reiterates | Buy → Buy | Get Alert |
| 02/03/2025 | Buy Now | 42.92% | JP Morgan | Ryan Brinkman53% | $34 → $32 | Maintains | Neutral | Get Alert |
| 11/21/2024 | Buy Now | 51.85% | Guggenheim | Ronald Jewsikow48% | $35 → $34 | Maintains | Buy | Get Alert |
| 10/28/2024 | Buy Now | 65.25% | Baird | David Leiker59% | $35 → $37 | Maintains | Outperform | Get Alert |
| 10/14/2024 | Buy Now | 56.32% | B of A Securities | John Murphy54% | $39 → $35 | Maintains | Neutral | Get Alert |
| 10/01/2024 | Buy Now | 38.45% | Goldman Sachs | Mark Delaney77% | $33 → $31 | Maintains | Neutral | Get Alert |
| 09/04/2024 | Buy Now | 51.85% | UBS | Joseph Spak43% | → $34 | Initiates | → Neutral | Get Alert |
| 07/29/2024 | Buy Now | 83.12% | B. Riley Securities | Josh Nichols50% | $44 → $41 | Maintains | Buy | Get Alert |
| 07/29/2024 | Buy Now | 69.72% | Baird | David Leiker59% | $40 → $38 | Maintains | Outperform | Get Alert |
| 07/22/2024 | Buy Now | 56.32% | JP Morgan | Ryan Brinkman53% | $36 → $35 | Maintains | Neutral | Get Alert |
| 07/12/2024 | Buy Now | 78.65% | Baird | David Leiker59% | $41 → $40 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 83.12% | Guggenheim | Ronald Jewsikow48% | $40 → $41 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 96.52% | B. Riley Securities | Josh Nichols50% | $42 → $44 | Maintains | Buy | Get Alert |
| 03/19/2024 | Buy Now | 78.65% | Guggenheim | Ronald Jewsikow48% | $38 → $40 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | 56.32% | Goldman Sachs | Mark Delaney77% | $31 → $35 | Maintains | Neutral | Get Alert |
| 01/29/2024 | Buy Now | 87.58% | B. Riley Securities | Josh Nichols50% | $36 → $42 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | 65.25% | JP Morgan | Ryan Brinkman53% | $36 → $37 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 65.25% | Baird | David Leiker59% | $35 → $37 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 78.65% | B. Riley Securities | Josh Nichols50% | $35 → $40 | Maintains | Buy | Get Alert |
| 07/31/2023 | Buy Now | 47.39% | Goldman Sachs | Mark Delaney77% | $29 → $33 | Maintains | Neutral | Get Alert |
| 07/20/2023 | Buy Now | 33.99% | JP Morgan | Ryan Brinkman53% | $28 → $30 | Maintains | Neutral | Get Alert |
| 07/19/2023 | Buy Now | 56.32% | B. Riley Securities | Josh Nichols50% | → $35 | Reinstates | Buy → Buy | Get Alert |
| 07/06/2023 | Buy Now | 47.39% | B of A Securities | John Murphy54% | $26 → $33 | Upgrade | Underperform → Neutral | Get Alert |
| 12/14/2022 | Buy Now | 16.12% | Goldman Sachs | Mark Delaney77% | $24 → $26 | Upgrade | Sell → Neutral | Get Alert |
| 07/25/2022 | Buy Now | 47.39% | Jefferies | David Kelley68% | $36 → $33 | Maintains | Buy | Get Alert |
| 07/25/2022 | Buy Now | 56.32% | B. Riley Securities | Josh Nichols50% | $37.5 → $35 | Maintains | Buy | Get Alert |
| 06/01/2022 | Buy Now | 11.66% | Goldman Sachs | Mark Delaney77% | $26 → $25 | Maintains | Sell | Get Alert |
FAQ
What is the target price for Gentex (GNTX) stock?
The latest price target for Gentex (NASDAQ:GNTX) was reported by Guggenheim on April 22, 2025. The analyst firm set a price target for $24.00 expecting GNTX to rise to within 12 months (a possible 7.19% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Gentex (GNTX)?
The latest analyst rating for Gentex (NASDAQ:GNTX) was provided by Guggenheim, and Gentex maintained their buy rating.
When was the last upgrade for Gentex (GNTX)?
The last upgrade for Gentex Corp happened on July 6, 2023 when B of A Securities raised their price target to $33. B of A Securities previously had an underperform for Gentex Corp.
When was the last downgrade for Gentex (GNTX)?
The last downgrade for Gentex Corp happened on April 15, 2025 when Baird changed their price target from $31 to $25 for Gentex Corp.
When is the next analyst rating going to be posted or updated for Gentex (GNTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gentex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gentex was filed on April 22, 2025 so you should expect the next rating to be made available sometime around April 22, 2026.
Is the Analyst Rating Gentex (GNTX) correct?
While ratings are subjective and will change, the latest Gentex (GNTX) rating was a maintained with a price target of $30.00 to $24.00. The current price Gentex (GNTX) is trading at is $22.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
